ClinVar Miner

Submissions for variant NM_020822.3(KCNT1):c.1421G>A (p.Arg474His)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 19
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
UCLA Clinical Genomics Center, UCLA RCV000032795 SCV000255509 pathogenic Developmental and epileptic encephalopathy, 14 2014-02-04 criteria provided, single submitter clinical testing
GeneDx RCV000414268 SCV000490584 pathogenic not provided 2023-07-13 criteria provided, single submitter clinical testing Published functional studies demonstrate a damaging effect, with increased channel activity but minor change in protein expression compared to the wild type variant (Kim et al., 2014); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 29455050, 32167590, 25482562, 25326637, 23086397, 26140313, 24315024, 25568878, 27779742, 27081515, 27652284, 28488083, 28987752, 29291456, 31872048, 31532509, 32081855, 31054119, 31532594, 31349857, 32139178, 32505479, 34489640, 33822359, 34055682, 35571021, 35365919, 36007526, 34580403, 31440721, 35715422, 34114611, 35346832, 37062836, 37177976)
Invitae RCV000546032 SCV000652908 pathogenic Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 2023-12-22 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 474 of the KCNT1 protein (p.Arg474His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with early onset epileptic encephalopathies, malignant migrating partial seizures of infancy, migrating focal seizure of infancy, and/or nocturnal frontal lobe epilepsy (PMID: 23086397, 25326637, 25482562, 26140313, 26740507). In at least one individual the variant was observed to be de novo. This variant is also known as c.1286G>A:p.R429H. ClinVar contains an entry for this variant (Variation ID: 39595). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNT1 protein function. This variant disrupts the p.Arg474 amino acid residue in KCNT1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 26140313, 27652284). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV000624507 SCV000741205 pathogenic Inborn genetic diseases 2015-11-20 criteria provided, single submitter clinical testing
Baylor Genetics RCV000032795 SCV000807326 pathogenic Developmental and epileptic encephalopathy, 14 2023-03-19 criteria provided, single submitter clinical testing
Laboratory of Medical Genetics, National & Kapodistrian University of Athens RCV000032795 SCV000928394 likely pathogenic Developmental and epileptic encephalopathy, 14 2018-12-03 criteria provided, single submitter clinical testing PS3, PM2, PM5, PP3
Génétique des Maladies du Développement, Hospices Civils de Lyon RCV000032795 SCV001164145 pathogenic Developmental and epileptic encephalopathy, 14 2017-02-14 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000414268 SCV001247123 pathogenic not provided 2019-05-01 criteria provided, single submitter clinical testing
Institute of Human Genetics, University of Leipzig Medical Center RCV001253027 SCV001428542 uncertain significance Autosomal dominant nocturnal frontal lobe epilepsy 5 2018-05-28 criteria provided, single submitter clinical testing
Institute of Human Genetics, University of Leipzig Medical Center RCV000032795 SCV001429527 pathogenic Developmental and epileptic encephalopathy, 14 2017-06-21 criteria provided, single submitter clinical testing
Neuberg Supratech Reference Laboratories Pvt Ltd, Neuberg Centre for Genomic Medicine RCV000032795 SCV002820286 likely pathogenic Developmental and epileptic encephalopathy, 14 criteria provided, single submitter clinical testing The missense variant p.R474H in KCNT1 (NM_020822.3) has been previously reported as a de novo variant in individuals with malignant migrating partial seizures of infancy (MMPSI) and West syndrome (Lee et al 2014; Barcia et al 2012; Ohba et al 2015). A different missense variant at the same position (R474C) has been reported as a pathogenic variant in individuals with epilepsy of infancy with migrating focal seizures (EIFMS) (Ohba et al, 2015). The variant has been submitted to ClinVar as Pathogenic. The p.R474H variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.R474H missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 474 of KCNT1 is conserved in all mammalian species. The nucleotide c.1421 in KCNT1 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic.
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV000032795 SCV003807651 pathogenic Developmental and epileptic encephalopathy, 14 2022-07-25 criteria provided, single submitter clinical testing ACMG classification criteria: PS3 supporting, PS4 strong, PM2 moderated, PM5 moderated, PM6 moderated, PP3 supporting
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden RCV000414268 SCV004026310 pathogenic not provided 2023-03-21 criteria provided, single submitter clinical testing PS4, PP3, PM2_SUP, PM5
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego RCV001253027 SCV004046120 pathogenic Autosomal dominant nocturnal frontal lobe epilepsy 5 criteria provided, single submitter clinical testing This variant has been previously reported as a de novo change in patients with malignant migrating partial seizures in infancy with and without systemic pulmonary collateral arteries (MMPSI) (PMID: 23086397, 28987752), malignant migrating focal seizures in infancy (PMID: 27779742), epilepsy of infancy with migrating focal seizures (EIMFS) (PMID: 31872048, 31532509, 32167590, 32505479) and sleep-related hypermotor epilepsy (PMID: 32167590). Overexpression studies demonstrated that this variant leads to increased Kcnt1 current amplitude (PMID: 25482562). It is absent from the gnomAD population database and thus is presumed to be rare. The c.1421G>A (p.Arg474His) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.1421G>A (p.Arg474His) variant is classified as Pathogenic.
Preventiongenetics, part of Exact Sciences RCV003390714 SCV004119738 pathogenic KCNT1-related condition 2023-04-12 criteria provided, single submitter clinical testing The KCNT1 c.1421G>A variant is predicted to result in the amino acid substitution p.Arg474His. This variant has been reported many times to have arisen de novo in individuals with infantile-onset epilepsy (see for examples Barcia et al. 2012. PubMed ID: 23086397; Ohba et al. 2015. PubMed ID: 26140313). A functional study found that the p.Arg474His variant causes an increase in activity of the encoded potassium channel (Kim et al. 2014. PubMed ID: 25482562), indicating a gain of function mechanism. This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating it is rare or absent in the general population. This variant has been interpreted as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/39595). Given all the evidence, we too interpret c.1421G>A (p.Arg474His) as pathogenic.
OMIM RCV000032795 SCV000056563 pathogenic Developmental and epileptic encephalopathy, 14 2012-11-01 no assertion criteria provided literature only
Pediatric Genetics Clinic, Sheba Medical Center RCV000032795 SCV001712189 pathogenic Developmental and epileptic encephalopathy, 14 2021-05-13 no assertion criteria provided clinical testing
Diagnostic Laboratory, Strasbourg University Hospital RCV002274887 SCV002562819 pathogenic Seizure no assertion criteria provided clinical testing
Center of Excellence for Medical Genomics, Chulalongkorn University RCV001253027 SCV002570033 pathogenic Autosomal dominant nocturnal frontal lobe epilepsy 5 2002-09-08 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.